114 related articles for article (PubMed ID: 7116649)
1. A practical method for screening atypical pseudocholinesterase.
Magna LA
Clin Chim Acta; 1982 Aug; 123(3):333-8. PubMed ID: 7116649
[No Abstract] [Full Text] [Related]
2. [A new method for the detection of atypical pseudocholinesterase].
Magna LA
Rev Paul Med; 1982; 99(2):8-11. PubMed ID: 7156681
[No Abstract] [Full Text] [Related]
3. Pseudocholinesterase variation.
Goedde HW; Agarwal DP
Hum Genet Suppl; 1978; (1):45-55. PubMed ID: 285032
[No Abstract] [Full Text] [Related]
4. Pseudocholinesterase-mediated hydrolysis is superior to neostigmine for reversal of mivacurium-induced paralysis in vitro.
Yang HS; Goudsouzian N; Martyn JA
Anesthesiology; 1996 Apr; 84(4):936-44. PubMed ID: 8638849
[TBL] [Abstract][Full Text] [Related]
5. Neostigmine and atypical plasma cholinesterase activity.
Baraka A
Br J Anaesth; 1981 Aug; 53(8):907-8. PubMed ID: 7272156
[No Abstract] [Full Text] [Related]
6. High incidence of the silent allele at cholinesterase locus I in Vysyas of Andhra Pradesh (S. India).
Rao PR; Gopalam KB
Hum Genet; 1979 Nov; 52(1):139-41. PubMed ID: 527975
[TBL] [Abstract][Full Text] [Related]
7. [Frequency of locus E1 variants of plasma butyrylcholinesterase in a French population].
Masson P; Germani F; Plasse M
C R Seances Acad Sci D; 1979 Oct; 289(6):537-9. PubMed ID: 118816
[TBL] [Abstract][Full Text] [Related]
8. Serum atypical pseudocholinesterase and leprosy.
Navarrete JI; Lisker R; Pérez-Briceńo R
Int J Dermatol; 1979 Dec; 18(10):822-3. PubMed ID: 528104
[TBL] [Abstract][Full Text] [Related]
9. An explanation for the different inhibitory characteristics of human serum butyrylcholinesterase phenotypes deriving from inhibition of atypical heterozygotes.
Simeon-Rudolf V; Kovarik Z; Skrinjarić-Spoljar M; Evans RT
Chem Biol Interact; 1999 May; 119-120():159-64. PubMed ID: 10421449
[TBL] [Abstract][Full Text] [Related]
10. Pseudocholinesterase activity and E1 phenotypes in Down's syndrome and mental retardation.
Propert DN
Hum Hered; 1979; 29(6):361-3. PubMed ID: 159860
[TBL] [Abstract][Full Text] [Related]
11. Serum cholinesterase (pseudocholinesterase) in Down's syndrome: 1. Phenotype frequencies at the E1 and E2 loci.
Drew AH; Rundle AT
J Ment Defic Res; 1977 Sep; 21(3):181-9. PubMed ID: 144799
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of eserine and neostigmine on the leech muscle preparation.
BHATTACHARYA BK; FELDBERG W
Br J Pharmacol Chemother; 1958 Jun; 13(2):151-5. PubMed ID: 13536279
[TBL] [Abstract][Full Text] [Related]
13. Effects of neostigmine and pyridostigmine on duration of succinylcholine action and pseudocholinesterase activity.
Sunew KY; Hicks RG
Anesthesiology; 1978 Sep; 49(3):188-91. PubMed ID: 686441
[No Abstract] [Full Text] [Related]
14. The effects of donepezil and neostigmine in a patient with unusual pseudocholinesterase activity.
Sprung J; Castellani WJ; Srinivasan V; Udayashankar S
Anesth Analg; 1998 Nov; 87(5):1203-5. PubMed ID: 9806710
[No Abstract] [Full Text] [Related]
15. Species- and concentration-dependent differences of acetyl- and butyrylcholinesterase sensitivity to physostigmine and neostigmine.
Bitzinger DI; Gruber M; Tümmler S; Michels B; Bundscherer A; Hopf S; Trabold B; Graf BM; Zausig YA
Neuropharmacology; 2016 Oct; 109():1-6. PubMed ID: 26772968
[TBL] [Abstract][Full Text] [Related]
16. Kinetic aspects of Taenia solium metacestode cholinesterases and their inhibition with DDVP and neostigmine.
Martínez-Zedillo G; González-Barranco D; Rebolledo-Camacho P; Lara-Nuñez MA
Arch Invest Med (Mex); 1984; 15(4):349-61. PubMed ID: 6535521
[No Abstract] [Full Text] [Related]
17. Evidence for a single butyrylcholinesterase gene in individuals carrying the C5 plasma cholinesterase variant (CHE2).
Masson P; Chatonnet A; Lockridge O
FEBS Lett; 1990 Mar; 262(1):115-8. PubMed ID: 2318303
[TBL] [Abstract][Full Text] [Related]
18. Pesticide poisoning, succinylcholine-induced apnea, and pseudocholinesterase.
Nelson TC; Burritt MF
Mayo Clin Proc; 1986 Sep; 61(9):750-2. PubMed ID: 3747617
[No Abstract] [Full Text] [Related]
19. Pseudocholinesterase variation in southern African populations.
Krause A; Lane AB; Jenkins T
S Afr Med J; 1987 Mar; 71(5):298-301. PubMed ID: 3563754
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of suxamethonium blockade by neostigmine in patients with atypical cholinesterase.
Baraka A
Br J Anaesth; 1975 Mar; 47(3):416-8. PubMed ID: 1138751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
